CANN
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Oct 4 closing price
CGC
Price
$4.31
Change
+$0.05 (+1.17%)
Updated
Oct 17 closing price
25 days until earnings call
Ad is loading...

CANN vs CGC

Header iconCANN vs CGC Comparison
Open Charts CANN vs CGCBanner chart's image
TREES
Price$0.05
Change-$0.00 (-0.00%)
Volume$10.26K
CapitalizationN/A
Canopy Growth
Price$4.31
Change+$0.05 (+1.17%)
Volume$2.36M
CapitalizationN/A
View a ticker or compare two or three
CANN vs CGC Comparison Chart
Loading...
CANN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CGC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CANN vs. CGC commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANN is a StrongSell and CGC is a Sell.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (CANN: $0.05 vs. CGC: $4.31)
Brand notoriety: CANN: Not notable vs. CGC: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CANN: 135% vs. CGC: 74%
Market capitalization -- CANN: $8.96M vs. CGC: $784.64M
CANN [@Pharmaceuticals: Other] is valued at $8.96M. CGC’s [@Pharmaceuticals: Other] market capitalization is $784.64M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANN’s FA Score shows that 0 FA rating(s) are green whileCGC’s FA Score has 0 green FA rating(s).

  • CANN’s FA Score: 0 green, 5 red.
  • CGC’s FA Score: 0 green, 5 red.
According to our system of comparison, CANN is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANN’s TA Score shows that 3 TA indicator(s) are bullish while CGC’s TA Score has 5 bullish TA indicator(s).

  • CANN’s TA Score: 3 bullish, 6 bearish.
  • CGC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CGC is a better buy in the short-term than CANN.

Price Growth

CANN (@Pharmaceuticals: Other) experienced а -5.64% price change this week, while CGC (@Pharmaceuticals: Other) price change was +8.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

CANN is expected to report earnings on Apr 17, 2023.

CGC is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($785M) has a higher market cap than CANN($8.96M). CGC YTD gains are higher at: -15.656 vs. CANN (-33.333). CANN has higher annual earnings (EBITDA): -6.77M vs. CGC (-1.02B). CGC has more cash in the bank: 186M vs. CANN (1.46M). CANN has less debt than CGC: CANN (22.9M) vs CGC (693M). CGC has higher revenues than CANN: CGC (362M) vs CANN (15M).
CANNCGCCANN / CGC
Capitalization8.96M785M1%
EBITDA-6.77M-1.02B1%
Gain YTD-33.333-15.656213%
P/E RatioN/AN/A-
Revenue15M362M4%
Total Cash1.46M186M1%
Total Debt22.9M693M3%
FUNDAMENTALS RATINGS
CANN vs CGC: Fundamental Ratings
CANN
CGC
OUTLOOK RATING
1..100
711
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6591
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CANN's Valuation (67) in the null industry is in the same range as CGC (94) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

CANN's Profit vs Risk Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

CGC's SMR Rating (98) in the Agricultural Commodities Or Milling industry is in the same range as CANN (100) in the null industry. This means that CGC’s stock grew similarly to CANN’s over the last 12 months.

CANN's Price Growth Rating (65) in the null industry is in the same range as CGC (91) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

CANN's P/E Growth Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANNCGC
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CANN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CGC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

CANN and

Correlation & Price change

A.I.dvisor tells us that CANN and SFOSF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANN and SFOSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANN
1D Price
Change %
CANN100%
+2.04%
SFOSF - CANN
21%
Poorly correlated
N/A
MEDIF - CANN
20%
Poorly correlated
+3.96%
CGC - CANN
20%
Poorly correlated
+1.17%
CAIHF - CANN
12%
Poorly correlated
N/A
CANSF - CANN
9%
Poorly correlated
N/A
More